Rapamycin rescues BMP mediated midline craniosynostosis phenotype through reduction of mTOR signaling in a mouse...

Area of Science:

• Developmental Biology
• Genetics
• Craniofacial Biology

Background:

• Craniosynostosis is premature fusion of cranial sutures, with unknown genetic causes for most cases.
• Cranial suture stem cells are crucial for skull development and understanding their regulation is key.
• Enhanced Bone Morphogenetic Protein (BMP) signaling in neural crest cells causes midline craniosynostosis.

Purpose of the Study:

• Investigate the role of mTOR signaling in BMP-mediated craniosynostosis.
• Determine if mTOR signaling affects cranial suture stem cells in this context.
• Identify therapeutic targets for craniosynostosis.

Main Methods:

• Utilized caA3 mutant mice with enhanced BMP signaling in neural crest cells.
• Examined suture stem cell populations at embryonic and newborn stages.
• Assessed mTOR signaling activation using Western blotting.
• Administered rapamycin to inhibit mTOR signaling in a time-specific manner.

Main Results:

• caA3 mutant mice exhibit a loss of cranial suture stem cells by the newborn stage.
• Increased mTOR signaling activation was observed during embryonic stages in caA3 mutants.
• Time-specific inhibition of mTOR signaling with rapamycin partially restored suture stem cell populations.
• BMP signaling appears to regulate suture stem cells through mTOR activation.

Conclusions:

• Enhanced BMP signaling contributes to craniosynostosis by depleting cranial suture stem cells.
• mTOR signaling is a critical mediator in the BMP-driven pathogenesis of craniosynostosis.
• Targeting the mTOR pathway may offer a therapeutic strategy for certain types of craniosynostosis.